The N-terminal domain of transcription factor IIB is required for direct interaction with the vitamin D receptor and participates in vitamin D-mediated transcription

被引:55
作者
Masuyama, H [1 ]
Jefcoat, SC [1 ]
MacDonald, PN [1 ]
机构
[1] ST LOUIS UNIV, HLTH SCI CTR, DEPT PHARMACOL & PHYSIOL SCI, ST LOUIS, MO 63104 USA
关键词
D O I
10.1210/me.11.2.218
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The interaction of the vitamin D receptor (VDR) with transcription factor IIB (TFIIB) represents a potential physical link between the VDR-DNA complex and the transcription preinitiation complex. However, the functional relevance of the VDR-TFIIB interaction in vitamin D-mediated transcription is not well understood. In the present study, we used site-directed mutagenesis to demonstrate that the structural integrity of the amino-terminal zinc finger of TFIIB is essential for VDR-TFIIB complex formation. Altering the putative zinc-coordinating residues (C15, C34, C37, or H18) to serines abolished TFIIB interaction with the VDR as assessed in a yeast two-hybrid system and by in vitro protein interaction assays. This N-terminal, VDR-interactive domain functioned as a selective, dominant-negative inhibitor of vitamin D-mediated transcription. Expressing amino acids 1-124 of human TFIIB (N-TFIIB) in COS-7 cells or in osteoblastic ROS17/2.8 cells effectively suppressed 1,25-dihydroxyvitamin D-3 (1,25-(OH)(2)D-3)-induced transcription, but had no effect on basal or glucocorticoid-activated transcription. A mutant N-terminal domain [N-TFIIB(C34S:C37S)] that does not interact with VDR had no impact on 1,25(OH)(2)D-3-induced transcription. Interestingly, both in vitro and in vivo protein interaction assays showed that the VDR-TFIIB protein complex was disrupted by the 1,25-(OH)(2)D-3 ligand. Mechanistically, these data establish a functional role for the N terminus of TFIIB in VDR-mediated transcription, and they allude to a role for unliganded VDR in targeting TFIIB to the promoter regions of vitamin D-responsive target genes.
引用
收藏
页码:218 / 228
页数:11
相关论文
共 49 条
[1]   DIFFERENTIATION OF MOUSE MYELOID-LEUKEMIA CELLS INDUCED BY 1-ALPHA,25-DIHYDROXYVITAMIN-D3 [J].
ABE, E ;
MIYAURA, C ;
SAKAGAMI, H ;
TAKEDA, M ;
KONNO, K ;
YAMAZAKI, T ;
YOSHIKI, S ;
SUDA, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (08) :4990-4994
[2]   SOLUTION STRUCTURE OF THE C-TERMINAL CORE DOMAIN OF HUMAN TFIIB - SIMILARITY TO CYCLIN-A AND INTERACTION WITH TATA-BINDING PROTEIN [J].
BAGBY, S ;
KIM, SJ ;
MALDONADO, E ;
TONG, KI ;
REINBERG, D ;
IKURA, M .
CELL, 1995, 82 (05) :857-867
[3]   INTERACTION OF HUMAN THYROID-HORMONE RECEPTOR-BETA WITH TRANSCRIPTION FACTOR TFIIB MAY MEDIATE TARGET GENE DEREPRESSION AND ACTIVATION BY THYROID-HORMONE [J].
BANIAHMAD, A ;
HA, I ;
REINBERG, D ;
TSAI, S ;
TSAI, MJ ;
OMALLEY, BW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (19) :8832-8836
[4]   DELINEATION OF 2 FUNCTIONAL REGIONS OF TRANSCRIPTION FACTOR-TFIIB [J].
BARBERIS, A ;
MULLER, CW ;
HARRISON, SC ;
PTASHNE, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (12) :5628-5632
[5]   Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1 [J].
Baur, EV ;
Zechel, C ;
Heery, D ;
Heine, MJS ;
Garnier, JM ;
Vivat, V ;
LeDouarin, B ;
Gronemeyer, H ;
Chambon, P ;
Losson, R .
EMBO JOURNAL, 1996, 15 (01) :110-124
[6]   TRANSCRIPTION FACTOR TFIIB AND THE VITAMIN-D RECEPTOR COOPERATIVELY ACTIVATE LIGAND-DEPENDENT TRANSCRIPTION [J].
BLANCO, JCG ;
WANG, IM ;
TSAI, SY ;
TSAI, MJ ;
OMALLEY, BW ;
JURUTKA, PW ;
HAUSSLER, MR ;
OZATO, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (05) :1535-1539
[7]   FUNCTIONAL DOMAINS OF TRANSCRIPTION FACTOR-TFIIB [J].
BURATOWSKI, S ;
ZHOU, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (12) :5633-5637
[8]  
CARTER P, 1987, METHOD ENZYMOL, V154, P382
[9]   A TRANSCRIPTIONAL CO-REPRESSOR THAT INTERACTS WITH NUCLEAR HORMONE RECEPTORS [J].
CHEN, JD ;
EVANS, RM .
NATURE, 1995, 377 (6548) :454-457
[10]   INTERACTION BETWEEN A TRANSCRIPTIONAL ACTIVATOR AND TRANSCRIPTION FACTOR-IIB INVIVO [J].
COLGAN, J ;
WAMPLER, S ;
MANLEY, JL .
NATURE, 1993, 362 (6420) :549-553